Response letter to the Editor

Affiliations

¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom. Electronic address: P.Conaghan@leeds.ac.uk.
² Merck KGaA, Darmstadt, Germany.
³ EMD Serono Research and Development Institute, Inc., Billerica, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
⁴ NBCD A/S, Herlev, Denmark.
⁵ Chondrometrics GmbH, Ainring, Germany; Department of Imaging and Functional Musculoskeletal Research, Institute of Anatomy & Cell Biology, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.
⁶ University of Maryland School of Medicine, Baltimore, MD, United States.

Free article

Comment

Philip G Conaghan et al. Semin Arthritis Rheum. 2022 Feb.

Free article

. 2022 Feb:52:151839.

doi: 10.1016/j.semarthrit.2021.05.001. Epub 2021 May 8.

¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom. Electronic address: P.Conaghan@leeds.ac.uk.
² Merck KGaA, Darmstadt, Germany.
³ EMD Serono Research and Development Institute, Inc., Billerica, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany.
⁴ NBCD A/S, Herlev, Denmark.
⁵ Chondrometrics GmbH, Ainring, Germany; Department of Imaging and Functional Musculoskeletal Research, Institute of Anatomy & Cell Biology, Paracelsus Medical University Salzburg & Nuremberg, Salzburg, Austria; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Paracelsus Medical University, Salzburg, Austria.
⁶ University of Maryland School of Medicine, Baltimore, MD, United States.

No abstract available

Conflict of interest statement

Declaration of Competing Interest None.

The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial.
Guehring H, Moreau F, Daelken B, Ladel C, Guenther O, Bihlet AR, Wirth W, Eckstein F, Hochberg M, Conaghan PG. Guehring H, et al. Semin Arthritis Rheum. 2021 Apr;51(2):450-456. doi: 10.1016/j.semarthrit.2021.03.005. Epub 2021 Mar 11. Semin Arthritis Rheum. 2021. PMID: 33752164 Clinical Trial.
Transparency and the reporting of subgroup analyses by Guehring and colleagues.
Riddle DL. Riddle DL. Semin Arthritis Rheum. 2021 Oct;51(5):e1. doi: 10.1016/j.semarthrit.2021.05.002. Epub 2021 May 8. Semin Arthritis Rheum. 2021. PMID: 34134895 No abstract available.